Browse every story filed under this topic, curated from trusted publishers around the world.
Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win
Mundipharma and CorMedix have announced a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in patients receiving allogeneic hematopoietic stem cell transplants.
Read full story →
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer …
US Supreme Court Reviews Police Use of Cell Location Data to Find Criminals
Comments
Lessons from the eye: How cell therapy is shaping the future of regenerative medicine
Astellas R&D leaders, Jotaro Suzuki, Marci English, and Erin Kimbrel, reflect on how cell therapy could change the future of …
Samsung's First Cell Phone Is Older Than You Probably Think
Samsung has a hand in just about every type of industry nowadays, notably the smartphone business. When did the company's …
Pancreatic cancer pill, vaccine show promise: What to know
Two potential pancreatic cancer treatments are gaining recognition within the oncology community, according to reports from The New York Times …
AAN 2026: BlueRock reports positive safety data for bemdaneprocel in Parkinson’s
Bemdaneprocel is a cell therapy composed of human embryonic stem cell-derived midbrain dopaminergic neuron progenitor cells The post AAN 2026: …
ModeX starts dosing in MDX2003 trial for B-cell lymphoma
ModeX Therapeutics has started dosing patients with its tetraspecific T-cell engager, MDX2003, for relapsed or refractory B-cell lymphoma. The post …
Work faster, not harder: Google Sheets just got a serious speed boost
Google is also rolling out a new beta that doubles your cell count.
An experimental new drug for stiff person syndrome restores mobility
CAR T cell therapy wipes out rogue antibodies' source and improves walking speed in people with the same autoimmune disorder …
Immunotherapy in locally advanced HNSCC: is there still room for new agents?
The treatment landscape for locally advanced head and neck squamous cell carcinoma (LA HNSCC) has changed significantly.
STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval
A one-time cell therapy from Kyverna Therapeutics for stiff person syndrome, a rare disease, improved mobility and reduced disabilities in …
Eli Lilly Makes Another In Vivo Genetic Medicines Move With $3.2B Kelonia Acquisition
Kelonia Therapeutics brings to Eli Lilly an in vivo cell therapy in early clinical development for multiple myeloma. The deal …
Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory
Novo Nordisk said it will approach regulators with the data on the SCD therapy in H2 2026. The post Novo …
New 7x Spending Offers, Amex Platinum Member Airfare, American Airlines Devalues Status, Award Taxes Skyrocket & More
All of that plus over $8K in annual fees, United blocks Polaris Lounge access, save up to 75% off your …
You've seen all articles for #cell.
Check back
soon
for new stories.